XML 21 R9.htm IDEA: XBRL DOCUMENT
v3.19.1

PROPERTY AND EQUIPMENT | 12 Months Ended
--- | ---
Dec. 31, 2018
Property, Plant and Equipment [Abstract] |
Property, Plant and Equipment Disclosure [Text Block] | Note 3 – Property and Equipment Property and equipment consists of the following:
|  | DECEMBER 31, |
|  | 2018 |  |  | 2017 |
Medical equipment and facilities |  | $ | 94,031,000 |  |  | $ | 95,923,000 |
Office equipment |  |  | 589,000 |  |  |  | 576,000 |
Deposits and construction in progress |  |  | 3,832,000 |  |  |  | 1,658,000 |
Deposits towards purchase of proton beam systems |  |  | 2,250,000 |  |  |  | 2,000,000 |
|  |  | 100,702,000 |  |  |  | 100,157,000 |
Accumulated depreciation |  |  | (54,008,000 | ) |  |  | (51,666,000 | )
Net property and equipment |  | $ | 46,694,000 |  |  | $ | 48,491,000 |
The Company has equipment that is secured under capitalized leases, which is included in Medical equipment and facilities, with a total cost of $46,559,000 and associated accumulated depreciation of $20,292,000 as of December 31, 2018 and a total cost of $44,758,000 and associated accumulated depreciation of $16,777,000 as of December 31, 2017. As of December 31, 2018, the Company has one idle Gamma Knife unit with a cumulative net book value of $729,000. There are currently no commitments to place into service or trade in this unit during 2019. As of December 31, 2018, the Company has $3,832,000 in construction in progress. The construction in progress consists of costs associated with the Company’s new Gamma Knife site, which began treating patients in January 2019, deposits payments made for two Cobalt-60 reloads, capitalized and imputed interest, and other costs associated with on-going projects of the Company. As of December 31, 2018, the Company has $2,250,000 in deposits toward the purchase of two MEVION S250i PBRT systems from Mevion. The Company has a commitment for the remaining balance for each system. The Company’s first MEVION S250 treated its first patient in April 2016. The Company has entered into a partnership agreement (LBE) with a radiation oncology physician group, which has contributed $400,000 towards the deposits on the third machine. The Company currently does not have customer contracts for the second and third units. The Company reviews the carrying value of these deposits for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value may not be recoverable. The Company has reviewed the deposits, in light of available information, as of December 31, 2018 and has not identified any impairment. See Note 11-Commitments and Contingencies for additional discussion on purchase commitments.

X
- References No definition available. + Details
Name: | us-gaap_PropertyPlantAndEquipmentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -URI http://asc.fasb.org/topic&trid=2155823 + Details
Name: | us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration